Summary
Two new glucose 6-phosphate dehydrogenase (G6PD) variants associated with chronic nonspherocytic hemolytic anemia were discovered. G6PD Kobe was found in a 16-year-old male associated with hemolytic crisis after upper respiratory infection. The enzyme activity of the variant was about 22% of that of the normal enzyme. The main enzymatic characteristics were slower than normal anodal electrophoretic mobility, high Km G6P, increased thermal-instability, an acidic pH optimum, and an extremely increased affinity for the substrate analogue, galactose 6-phosphate (Gal-6P).
G6PD Sapporo was found in a 3-year-old male associated with drug-induced hemolysis. The enzyme activity was extremely low, being 3.6% of normal. In addition, this variant showed high Ki NADPH and thermal-instability.
G6PD Kobe utilized the artificial substrate Gal-6P effectively as compared with the common natural substrate, glucose 6-phosphate. In G6PD Sapporo, NADPH could not exert the effect of product inhibition. The structural changes of these variants are expected to occur at the portions inducing conformational changes of the substrate binding site of the enzyme.
Similar content being viewed by others
References
Beutler E, Mathai CK, Smith JE (1968) Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood 31:131–150
Beutler E, Yoshida A (1973) Human glucose-6-phosphate dehydrogenase variants: A supplementary tabulation. Ann Hum Genet 37:151–155
Dacie JV, Lewis SM (1975) Practical haematology, 5th ed. Churchill Livingstone, Edinburgh
Fairbanks VF, Nepo AG, Beutler E, Dickson ER, Honig G (1980) Glucose-6-phosphate dehydrogenase variants: Reexamination of G6PD Chicago and Cornell and a new variant (G6PD Pea Ridge) resembling G6PD Chicago. Blood 55:216–220
Fujii H, Krietsch WGK, Yoshida A (1980a) A single amino acid substitution (Asp→Asn) in a phosphoglycerate kinase variant (PGK München) associated with enzyme deficiency. J Biol Chem 255: 6421–6423
Fujii H, Yoshida A (1980b) Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia. Proc Natl Acad Sci USA 77:5461–5465
Fujii H, Chen S-H, Akatsuka J, Miwa S, Yoshida A (1981) Use of cultured lymphoblastoid cells for the study of abnormal enzymes: Molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia. Proc Natl Acad Sci USA 78:2587–2590
Mathai CK, Ohno S, Beutler E (1966) Sex-linkage of the glucose-6-phosphate dehydrogenase gene in Equidae. Nature 210:115–117
Report of WHO Scientific Group (1967) Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. WHO Tech Rep Ser 366:1–53
Yoshida A, Beutler E, Motulsky AG (1971) Human glucose-6-phosphate dehydrogenase variants. Bull WHO 45:243–253
Yoshida A (1973) Hemolytic anemia and G6PD deficiency: Physiologic activity, not in vitro activity, of enzyme is related to the severity of genetic disease. Science 179:532–537
Yoshida A, Beutler E (1978) Human glucose-6-phosphate dehydrogenase variants: A supplementary tabulation. Ann Hum Genet 41:347–355
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujii, H., Miwa, S., Tani, K. et al. Glucose 6-Phosphate dehydrogenase variants: A unique variant (G6PD Kobe) showed an extremely increased affinity for galactose 6-phosphate and a new variant (G6PD Sapporo) resembling G6PD Pea Ridge. Hum Genet 58, 405–407 (1981). https://doi.org/10.1007/BF00282823
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00282823